Custom Vault Corporation

Rating: 0 - Write A Review
4 Research Drive
Bethel, CT 06801
About Custom Vault Corporation
  • DEA Validated (21CFR 1301.72) modular vault systems for secure storage of Schedule I and II controlled substances are complemented by safes for smaller quantities, wire cages for Schedule III, IV and V; pallet rack solutions for inventory management and ThermaSure Chambers for temperature control. Electronic security equipment - video surveillance, intrusion alarm and access control – also available.
Competitors of Custom Vault Corporation
  • Gibraltar Laboratories, Inc.

    This 40 year old company has an outstanding reputation for customer service, quality research, quality control and testing in bacteriology, mycology, virology, chemistry and in vitrotoxicology. Gibraltar Laboratories Inc. serves the pharmaceutical, medical device, orthopedic, tissue bank,... Read More
  • Baxter BioPharma Solutions

    With more than 85 years as a parenterals specialist, Baxter’s BioPharma Solutions business offers contract manufacturing form/fill/finish services and solutions for injectables designed to meet complex and traditional sterile manufacturing challenges. We are a leading contract manufacturer of... Read More
  • Intellitech Inc.

    Intellitech, Inc. manufactures the i-FILL family of precision liquid filling pumps and intelliFILLER benchtop, semi- and fully automatic liquid filling / closure equipment. Customers enjoy the equipment’s unmatched repeatable dispense accuracy, ease of use, no tool setup & changeover.... Read More
Products by Custom Vault Corporation
  • Modular Vault Solutions

    CustomVault modular options for 21 CFR 1301.72 Schedule I-II compliance include the LightWeight™, MegaVault™ and HighBay™ Vault. Notably, the CustomVault HighBay™ Vault system compensates for restricted footprints by leveraging vertical space to accommodate controlled substance storage needs. Read more
  • Security Cages

    CustomVault designs and installs wire cage solutions that meet or exceed requirements dictated by DEA Specification 21 CFR 1301.72 for Schedule III-V pharmaceuticals. Read more